Enteroinsular hormones in two siblings with Donohue syndrome and complete leptin deficiency

2017 ◽  
Vol 19 (4) ◽  
pp. 675-679
Author(s):  
M Güemes ◽  
SA Rahman ◽  
P Shah ◽  
K Hussain
Keyword(s):  
Leptin Deficiency ◽  
Donohue Syndrome

scholarly journals Role and Regulation of Adipokines during Zymosan-Induced Peritoneal Inflammation in Mice

Endocrinology ◽  
2008 ◽  
Vol 149 (8) ◽  
pp. 4080-4085 ◽  
Author(s):  
Maria Pini ◽  
Melissa E. Gove ◽  
Joseph A. Sennello ◽  
Jantine W. P. M. van Baal ◽  
Lawrence Chan ◽  
...  
Keyword(s):  
Inflammatory Infiltrate ◽  
Peritoneal Lavage ◽  
Lavage Fluid ◽  
Wild Type ◽  
Cellular Infiltrate ◽  
Peritoneal Lavage Fluid ◽  
Peritoneal Inflammation ◽  
Leptin Deficiency ◽  
Cytokine Levels

Adipokines, cytokines mainly produced by adipocytes, are active participants in the regulation of inflammation. Administration of zymosan (ZY) was used to investigate the regulation and role of adipokines during peritonitis in mice. Injection of ZY led to a significant increase in leptin levels in both serum and peritoneal lavage fluid, whereas a differential trend in local vs. systemic levels was observed for both resistin and adiponectin. The role of leptin in ZY-induced peritonitis was investigated using leptin-deficient ob/ob mice, with and without reconstitution with exogenous leptin. Leptin deficiency was associated with delayed resolution of peritoneal inflammation induced by ZY, because ob/ob mice had a more pronounced cellular infiltrate in the peritoneum as well as higher and prolonged local and systemic levels of IL-6, TNFα, IL-10, and chemokine (C-X-C motif) ligand 2 compared with wild-type mice. Reconstitution with exogenous leptin exacerbated the inflammatory infiltrate and systemic IL-6 levels in ob/ob mice while inhibiting production of TNFα, IL-10, and chemokine (C-X-C motif) ligand 2. In contrast with the important role of leptin in regulating each aspect of ZY-induced peritonitis, adiponectin deficiency was associated only with a decreased inflammatory infiltrate, without affecting cytokine levels. These findings point to a complex role for adipokines in ZY-induced peritonitis and further emphasize the interplay between obesity and inflammation.

Areolar Sebaceous Hyperplasia With Underlying Primary Duct Carcinoma of the Breast in a Woman With Donohue Syndrome (Leprechaunism)

2012 ◽  
Vol 34 (2) ◽  
pp. e15-e18 ◽  
Author(s):  
Angel Fernandez-Flores ◽  
Saul Valerdiz ◽  
Luis G. Crespo ◽  
Purificacion Rodriguez-Cernuda
Keyword(s):  
Carcinoma Of The Breast ◽  
Duct Carcinoma ◽  
Donohue Syndrome

Upregulation of the leptin receptor as a mechanism to overcome leptin deficiency in apoptotic processes and miscarriages

2014 ◽  
Vol 101-102 ◽  
pp. 54
Author(s):  
Aurelia Pestka ◽  
B. Toth ◽  
C. Kuhn ◽  
I. Wiest ◽  
C. Hoffmann ◽  
...  
Keyword(s):  
Leptin Receptor ◽  
Leptin Deficiency

Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system

2002 ◽  
Vol 123 (4) ◽  
pp. 1304-1310 ◽  
Author(s):  
Zhiping Li ◽  
Huizhi Lin ◽  
Shiqi Yang ◽  
Anna Mae Diehl
Keyword(s):  
Immune System ◽  
Kupffer Cell ◽  
Innate Immune System ◽  
Innate Immune ◽  
Cell Production ◽  
Leptin Deficiency

Leptin deficiency linked to human obesity at last

The Lancet ◽  
1997 ◽  
Vol 349 (9069) ◽  
pp. 1889 ◽  
Author(s):  
Jane Bradbury
Keyword(s):  
Human Obesity ◽  
Leptin Deficiency

scholarly journals Leptin deficiency protects against SLE

2016 ◽  
Vol 12 (12) ◽  
pp. 688-688
Author(s):  
David Holmes
Keyword(s):  
Leptin Deficiency

Donohue Syndrome (Leprechaunism): A Case Report

2013 ◽  
Vol 12 (4) ◽  
pp. 189-192
Author(s):  
Engin Tutar ◽  
Ayse Karakas ◽  
Perran Boran ◽  
Berkin Berk ◽  
Sercin Bayar Guven
Keyword(s):  
Case Report ◽  
Donohue Syndrome

scholarly journals GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans

2019 ◽  
Vol 180 (2) ◽  
pp. R59-R71 ◽  
Author(s):  
Aimilia Eirini Papathanasiou ◽  
Eric Nolen-Doerr ◽  
Olivia M Farr ◽  
Christos S Mantzoros
Keyword(s):  
Energy Homeostasis ◽  
Endocrine System ◽  
Current Evidence ◽  
Energy Reserves ◽  
Neuroendocrine Function ◽  
Available Energy ◽  
Neuroendocrine Response ◽  
Leptin Deficiency ◽  
Molecular Signals ◽  
The Brain

The discovery of leptin, an adipocyte-secreted hormone, set the stage for unraveling the mechanisms dictating energy homeostasis, revealing adipose tissue as an endocrine system that regulates appetite and body weight. Fluctuating leptin levels provide molecular signals to the brain regarding available energy reserves modulating energy homeostasis and neuroendocrine response in states of leptin deficiency and to a lesser extent in hyperleptinemic states. While leptin replacement therapy fails to provide substantial benefit in common obesity, it is an effective treatment for congenital leptin deficiency and states of acquired leptin deficiency such as lipodystrophy. Current evidence suggests that regulation of eating behavior in humans is not limited to homeostatic mechanisms and that the reward, attention, memory and emotion systems are involved, participating in a complex central nervous system network. It is critical to study these systems for the treatment of typical obesity. Although progress has been made, further studies are required to unravel the physiology, pathophysiology and neurobehavioral mechanisms underlying potential treatments for weight-related problems in humans.

Abstract 509: Myocardial Fatty Acid Oxidation Rates Remain Elevated in ob/ob Mice Despite Reversal of Obesity and Diabetes by Caloric Restriction

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Crystal Sloan ◽  
Joseph Tuinei ◽  
E. Dale Abel
Keyword(s):  
Insulin Resistance ◽  
Glucose Tolerance ◽  
Cardiac Hypertrophy ◽  
Caloric Restriction ◽  
Serum Triglyceride ◽  
Palmitate Oxidation ◽  
Oxidation Rates ◽  
Leptin Deficiency ◽  
Obesity And Diabetes ◽  
Myocardial Substrate

Leptin deficient ob/ob mice are commonly used to study the effects of obesity and insulin resistance on myocardial substrate metabolism. However, it is difficult to discern the specific contribution of obesity, insulin resistance and diabetes versus leptin deficiency to the observed phenotypes. We therefore adopted a strategy using caloric restriction to normalize body weight and reverse insulin resistance to study the effect of leptin deficiency on myocardial metabolism in lean ob/ob mice. Male 4-week old ob/ob mice were “pair fed” to a leptin-treated group (3mg/kg/day by i.p. injection) for three weeks. Glucose tolerance, serum insulin, serum triglycerides and FA oxidation rates in hearts perfused with 0.4mM palmitate ± 1 nM insulin were determined. Leptin-treated ob/ob mice ate significantly less than non-treated ob/ob mice, and their weight returned to wild type levels. Hyperglycemia, hyperinsulinemia, hypertriglyceridemia and cardiac hypertrophy were also completely reversed in leptin-treated ob/ob mice. In contrast, cardiac hypertrophy persisted in pair fed ob/ob mice and despite normalization of glucose tolerance and insulin levels, serum triglyceride concentrations increased by 2 and 6 -fold in pair fed ob/ob mice relative to untreated ob/ob and wildtype mice respectively (p<0.05). As previously reported, palmitate oxidation rates were 2.1-fold increased in ob/ob hearts relative to controls (p<0.005) and were normalized with leptin treatment. In contrast, palmitate oxidation rates remained elevated in pair fed ob/ob mice relative to wildtype controls (1.9-fold, p<0.01). Insulin has a positive inotropic effect in perfused wildtype hearts, and this effect was absent in ob/ob hearts. The insulin-induced inotropic response was restored by leptin treatment in ob/ob mice but was not restored in pair fed ob/ob mice. These data support a direct antihypertrophic effect of leptin in the heart and suggest that leptin deficiency may directly contribute to myocardial insulin resistance and abnormal FA metabolism. Potential mechanisms include increased hepatic triglyceride production in leptin deficiency or direct effects of leptin signaling in the hypothalamus and/or the periphery on myocardial substrate utilization.

Sign in / Sign up

Export Citation Format

Share Document